JATT · JATT II Acquisition Corp.

JATT II Acquisition Corp, a special purpose acquisition company (SPAC), successfully closed its initial public offering, marking its transition to a publicly traded entity on the Nasdaq Global Market under the ticker 'JATT'. The IPO and concurrent private placement with its sponsor, JATT Ventures II L.P., collectively funded a $60 million trust account, which is a standard SPAC structure designed to protect public shareholder funds until a business combination is completed. This capital is restricted, with release conditions tightly defined to align with shareholder interests, including a 24-month deadline to consummate a business combination. The appointment of four independent directors with assigned committee leadership roles establishes a governance framework required for a publicly listed company. The suite of executed agreements, particularly the letter agreement and indemnity agreements with officers and directors, along with the sponsor's waiver of redemption rights for its private placement shares, are mechanisms to mitigate conflicts of interest and align incentives toward completing a successful business combination. The company's stated focus is on healthcare and biotechnology targets, leveraging data-driven approaches, though no specific target has been identified.